1011 · China NT Pharma Group Co., Ltd.
0.30
HKDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
HK$521.00M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 16/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- Big Candle
- HALO All
- Near Support
Key Fundamentals
EPS 3 yr Growth
-87.90%
EBITDA Margin
-48.40%
Operating Cashflow
-¥25m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-0.40
Quick Ratio
0.00
Performance
52 weeks range
Low 0.27 - 1
Trade Value (12mth)
US$5,283.00
1 week
-29.27%
1 month
-25.64%
YTD
-65.88%
1 year
-67.78%
All time high
42.90
Additional Data
Shares Outstanding (Fully Diluted)
821m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| Hong Li Chen | Individual |
| Gen Huo Zhang | Individual |
| Yong bin Lou | Individual |
